Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",erythrocyte size trait,,RS:0000681,SD,male,85 days to 71 days,6,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,11.57,%,0.1388,0.34,MMO:0000160,unspecified method,,0.0,,,,,control condition,84963,control condition, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",erythrocyte size trait,,RS:0000681,SD,male,85 days to 71 days,6,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,12.35,%,0.2409,0.59,MMO:0000160,unspecified method,,0.0,,,,,acetaminophen (250 mg/kg) (for 28 days),84964,acetaminophen (250 mg/kg) (for 28 days), 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",erythrocyte size trait,,RS:0000681,SD,male,85 days to 71 days,6,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,11.97,%,0.0939,0.23,MMO:0000160,unspecified method,,0.0,,,,,acetaminophen (500 mg/kg) (for 28 days),84965,acetaminophen (500 mg/kg) (for 28 days), 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",erythrocyte size trait,,RS:0000681,SD,male,85 days to 71 days,6,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,11.87,%,0.1796,0.44,MMO:0000160,unspecified method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 28 days),84966,acetaminophen (1000 mg/kg) (for 28 days), 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",erythrocyte size trait,,RS:0000681,SD,male,99 days to 85 days,6,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,11.9,%,0.1837,0.45,MMO:0000160,unspecified method,,0.0,,,,,control condition,84967,control condition, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",erythrocyte size trait,,RS:0000681,SD,male,99 days to 85 days,6,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,11.73,%,0.1796,0.44,MMO:0000160,unspecified method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 28 days),84968,acetaminophen (1000 mg/kg) (for 28 days), 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",erythrocyte size trait,,RS:0000681,SD,female,85 days to 71 days,6,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,10.98,%,0.3184,0.78,MMO:0000160,unspecified method,,0.0,,,,,control condition,84969,control condition, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",erythrocyte size trait,,RS:0000681,SD,female,85 days to 71 days,6,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,11.38,%,0.3674,0.9,MMO:0000160,unspecified method,,0.0,,,,,acetaminophen (250 mg/kg) (for 28 days),84970,acetaminophen (250 mg/kg) (for 28 days), 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",erythrocyte size trait,,RS:0000681,SD,female,85 days to 71 days,6,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,12.62,%,0.3225,0.79,MMO:0000160,unspecified method,,0.0,,,,,acetaminophen (500 mg/kg) (for 28 days),84971,acetaminophen (500 mg/kg) (for 28 days), 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",erythrocyte size trait,,RS:0000681,SD,female,85 days to 71 days,6,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,11.13,%,0.347,0.85,MMO:0000160,unspecified method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 28 days),84972,acetaminophen (1000 mg/kg) (for 28 days), 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",erythrocyte size trait,,RS:0000681,SD,female,99 days to 85 days,6,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,11.32,%,0.2409,0.59,MMO:0000160,unspecified method,,0.0,,,,,control condition,84973,control condition, 1602,"Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5.",erythrocyte size trait,,RS:0000681,SD,male,99 days to 85 days,6,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,11.35,%,0.1551,0.38,MMO:0000160,unspecified method,,0.0,,,,,acetaminophen (1000 mg/kg) (for 28 days),84974,acetaminophen (1000 mg/kg) (for 28 days), 2971,"Yao X and Verkman AS, Acta Neuropathol Commun. 2017 Feb 17;5(1):15. doi: 10.1186/s40478-017-0417-9.",erythrocyte size trait,,RS:0004626,SD-Cd59em1Ask+/+,both,70 days to 56 days,6,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,13.3,%,0.939,2.3,MMO:0000174,automated hematology analysis,,0.0,,,,,control condition (between 56 and 70 days),104625,control condition (between 56 and 70 days), 2971,"Yao X and Verkman AS, Acta Neuropathol Commun. 2017 Feb 17;5(1):15. doi: 10.1186/s40478-017-0417-9.",erythrocyte size trait,,RS:0004625,SD-Cd59em1Ask-/-,both,70 days to 56 days,6,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,14.2,%,0.8165,2.0,MMO:0000174,automated hematology analysis,,0.0,,,,,control condition (between 56 and 70 days),104626,control condition (between 56 and 70 days), 2989,"Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429.",erythrocyte size trait,,RS:0004633,SD-Fhem1+/+,male,0 days,3,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,17.3,%,0.4041,0.7,MMO:0000179,automated blood analysis,,0.0,,,,,control condition,104913,control condition, 2989,"Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429.",erythrocyte size trait,,RS:0004633,SD-Fhem1+/+,female,0 days,3,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,14.6,%,1.9053,3.3,MMO:0000179,automated blood analysis,,0.0,,,,,control condition,104914,control condition, 2989,"Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429.",erythrocyte size trait,,RS:0004632,SD-Fhem1+/-,male,0 days,3,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,19.6,%,0.8083,1.4,MMO:0000179,automated blood analysis,,0.0,,,,,control condition,104915,control condition, 2989,"Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429.",erythrocyte size trait,,RS:0004632,SD-Fhem1+/-,female,0 days,3,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,16,%,0.6928,1.2,MMO:0000179,automated blood analysis,,0.0,,,,,control condition,104916,control condition, 3026,"Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013.",erythrocyte size trait,,RS:0001827,Crl:LE,male,30 days,4,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,13.4,%,0.16,0.32,MMO:0000174,automated hematology analysis,,,,,,,control condition (for 30 days),106212,control condition (for 30 days), 3026,"Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013.",erythrocyte size trait,,RS:0003393,LE-Lrrk2em1Sage-/-,male,30 days,4,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,13.3,%,0.17,0.34,MMO:0000174,automated hematology analysis,,,,,,,control condition (for 30 days),106213,control condition (for 30 days), 3026,"Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013.",erythrocyte size trait,,RS:0001827,Crl:LE,male,60 days,4,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,11,%,0.05,0.1,MMO:0000174,automated hematology analysis,,,,,,,control condition (for 60 days),106266,control condition (for 60 days), 3026,"Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013.",erythrocyte size trait,,RS:0003393,LE-Lrrk2em1Sage-/-,male,60 days,4,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,11,%,0.3,0.6,MMO:0000174,automated hematology analysis,,,,,,,control condition (for 60 days),106267,control condition (for 60 days), 3026,"Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013.",erythrocyte size trait,,RS:0001827,Crl:LE,male,480 days,4,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,13.2,%,0.14,0.28,MMO:0000174,automated hematology analysis,,,,,,,control condition (for 480 days),106320,control condition (for 480 days), 3026,"Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013.",erythrocyte size trait,,RS:0003393,LE-Lrrk2em1Sage-/-,male,480 days,4,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,12.2,%,0.04,0.08,MMO:0000174,automated hematology analysis,,,,,,,control condition (for 480 days),106321,control condition (for 480 days), 3097,"Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e.",erythrocyte size trait,"MCV, RDW%",RS:0001789,BDIX/CrCrl,male,56 days,20,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,16.4,%,0.0224,0.1,MMO:0000174,automated hematology analysis,,0.0,,,,,DHD/K12/TRb cells (1.5 X 10E6) ,107845,DHD/K12/TRb cells (1.5 X 10E6) , 3097,"Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e.",erythrocyte size trait,"MCV, RDW%",RS:0001789,BDIX/CrCrl,male,71 days,10,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,16.9,%,0.2214,0.7,MMO:0000174,automated hematology analysis,,0.0,,,,,DHD/K12/TRb cells (1.5 X 10E6) then vehicle control condition (1 ml) ,107846,DHD/K12/TRb cells (1.5 X 10E6) ,vehicle control condition (1 ml) 3097,"Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e.",erythrocyte size trait,"MCV, RDW%",RS:0001789,BDIX/CrCrl,male,71 days,10,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,16.9,%,0.1581,0.5,MMO:0000174,automated hematology analysis,,0.0,,,,,DHD/K12/TRb cells (1.5 X 10E6) then sanguinarine (5 mg/kg/d) ,107847,DHD/K12/TRb cells (1.5 X 10E6) ,sanguinarine (5 mg/kg/d) 3097,"Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e.",erythrocyte size trait,"MCV, RDW%",RS:0001789,BDIX/CrCrl,male,92 days,10,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,17.7,%,0.1265,0.4,MMO:0000174,automated hematology analysis,,0.0,,,,,DHD/K12/TRb cells (1.5 X 10E6) then vehicle control condition (1 ml) ,107848,DHD/K12/TRb cells (1.5 X 10E6) ,vehicle control condition (1 ml) 3097,"Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e.",erythrocyte size trait,"MCV, RDW%",RS:0001789,BDIX/CrCrl,male,92 days,10,,CMO:0000041,red blood cell distribution width-coefficient of variation,,,,17,%,0.2214,0.7,MMO:0000174,automated hematology analysis,,0.0,,,,,DHD/K12/TRb cells (1.5 X 10E6) then sanguinarine (5 mg/kg/d) ,107849,DHD/K12/TRb cells (1.5 X 10E6) ,sanguinarine (5 mg/kg/d)